1. Home
  2. PESI vs PLX Comparison

PESI vs PLX Comparison

Compare PESI & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

HOLD

Current Price

$16.78

Market Cap

208.1M

Sector

Industrials

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.32

Market Cap

182.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PESI
PLX
Founded
1990
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.1M
182.9M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
PESI
PLX
Price
$16.78
$2.32
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
494.2K
528.7K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
43.61
N/A
EPS
N/A
0.22
Revenue
$642,000.00
$52,744,000.00
Revenue This Year
$34.62
$36.81
Revenue Next Year
$77.02
N/A
P/E Ratio
N/A
$10.77
Revenue Growth
N/A
N/A
52 Week Low
$8.14
$1.42
52 Week High
$18.40
$3.19

Technical Indicators

Market Signals
Indicator
PESI
PLX
Relative Strength Index (RSI) 62.46 55.08
Support Level $12.10 $2.06
Resistance Level $18.40 $2.44
Average True Range (ATR) 1.42 0.10
MACD -0.08 -0.01
Stochastic Oscillator 61.92 58.95

Price Performance

Historical Comparison
PESI
PLX

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: